Nintedanib in combination with docetaxel for second-line treatment of advanced non-small-cell lung cancer; GENESIS-SEFH drug evaluation report - Espinosa Bosch, María; Asensi Díez, Rocío; García Agudo, Sara; Clopés Estela, Ana; [Espinosa Bosch, M; Asensi Díez, R; García Agudo,S] Hospital Regional de Málaga, Málaga. [Clopés Estela,A] Hospital Duran I Reynals. Institut Català d’Oncologia. Hospitalet, Barcelona. Spain. (Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2016)